Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality.

A new collaboration between researchers at Indiana University Southeast and Bellarmine University in Kentucky, both in the USA, aimed to investigate what happens when a physical therapist and a music ...

Huntington’s disease causes unintentional movements, as well as difficulty walking and controlling movements. Dementia, which is a decline in cognitive abilities, is part of Huntington’s disease. The ...

The medications approved by the Food and Drug Administration (FDA) for treating Huntington’s disease chorea are Xenazine (tetrabenazine), Ingrezza (valbenazine) and Austedo (deuterabenazine).

Scientists have discovered a previously unknown pathway that allows toxic proteins linked to Huntington’s disease to spread ...

Researchers discovered that two proteins drive nanotube formation, allowing toxic protein transfer between neurons in ...

Findings from preclinical studies could point to therapeutic strategies for Huntington’s disease, as well as other neurodegenerative disorders and potentially cancer.

TAMPA, Fla. (WFLA) — For the first time, scientists have successfully treated someone suffering from Huntington’s disease, a fatal genetic illness with no cure. Assault at Mobile McDonald’s leaves man ...

Researchers found that targeting a protein fragment, huntingtin 1a, restored baseline gene activity and reduced aggregate ...

Synaptic plasticity—the brain's ability to modify the connections between neurons to support learning—is one of the neural functions profoundly altered in Huntington's disease, with a direct impact on ...